FCVB Topic Lecture in Hôpital ophtalmique Jules-Goni

24th May 2019, The famous Greek Vitreoretinal Specialist from Athens Retina Institute, Prof. Dr. Stratos Gotzaridis was invited to the Retinal Conference which hosted by Hôpital ophtalmique Jules-Gonin in Switzerland. A special topic lecture on Foldable Capsular Vitreous Body was presented at the conference by him.

The First FCVB Implantation Surgery in Latvia!

13th May 2019, Prof. Dr. Guna Laganovska from Pauls Stradins Clinical University Hospital performed the first FCVB implantation surgery in Riga, Latvia.v

Meet the FCVB Experts in the Moorfields

9th May 2019, the developer of FCVB, Professor Gao was invited to attend an meaningful meeting about FCVB with Dr. Wickham and Dr. Henderson -ophthalmologists from the Moorfields Eye Hospital – London.

The visit of Dr. Hunter Yuen and Dr. Kelvin Chong from to Vesber new factory in Nansha

On April 13th, Dr. Hunter Yuen and Dr. Kelvin Chong from The Chinese University of Hong Kong, came to visit Vebser new factory in Nansha district.

The general manager of Vesber, Mr. Gao introduced the company’s overall situation and shared his research and development process of Foldable Capsular Vitreous Body to professors. Subsequently, Mr. Gao guided  the visit to the fourth floor exhibition hall which shows the 17 years of research and development of FCVB and crucial nodes during the development .

During the meeting, Manager Gao made a detailed introduction of FCVB to guests and showed FCVB’s  folding steps.  The conversation is a good opportunity to know ideas and thoughts from KOL ophthalmologists and these advice will make FCVB and Vesber becoming better.  Vesber sincerely welcomes the domestic and foreign customers in this to come to visit and discuss.


Vesber Participates in Planting Activities of Nansha Technology Forest Tree

To beautify the Nansha ecological environment, the Nansha District Committee and the District Government held the Planting Activities of Nansha Technology Forest Tree at the Nansha Binhai Park at 11:00 am on April 4, 2019. The developer of FCVB, general manager of Vesber, Dr. Gao was also into this activity.

The Member of Standing Committee, the Nansha District Committee Mr. Cai Chaolin planned and organized personally. Besides, the deputy secretary of the District Committee, the executive deputy head of the district Mr. Dong Ke and the deputy director of the Nansha Development Zone Administrative Committee Mr. Xie Ming all visited the site, together with the invited owners of more than 60 well-known enterprises to plant 200 cherry trees next to the observation tower of Nansha Binhai Park.

As the geometric center of the Guangdong-Hong Kong-Macao Greater Bay Area, Nansha is growing like the cherry saplings we planted.

FCVB show in APAO 2019

Vesber team represented successfully at this year’s APAO Congress in Bangkok, Thailand from 6th-9th March. Excellent presentations have been prepared at booth G98 during the congress, attracting lots of interests for information about the global innovative product/treatment- Foldable Capsular Vitreous Body.

Dr. Prof. Hussain Ahmad Khaqan at Shaukat Khanum Memorial Cancer Hospital, Pakistan give us an impressive FCVB presentation regarding the surgical procedure of FCVB implantation surgery and the postoperative observation on the first day of congress, 6th of March.

On the second day of congress, 7th of March, Dr. Lin from Zhongshan Opthalmic Center, China gave us an excellent presentation about the reason why FCVB could be  the first choice for ocular trauma and phthisis treatment and its major working principal based on his abundant experience in using FCVB.

Thank you Dr. Prof. Hussain Ahmad Khaqan and Dr. Prof. Lin for educational introductions about FCVB surgical skills on our booth. We also would like to show our thanks to all present ophthalmologists and hope FCVB could be a good method for your future phthisis and ocular trauma treatment.

Opening ceremony of the new office of the company Vesber

On March 03, 2019 a milestone event was celebrated by Vesber Biotechnology Co.,–an official opening ceremony was held to new branch at Guangdong Medical Center, Nansha District, in Guangzhou.

The ceremony of a new building opening was attended by the Deputy Director of the Management Committee of Nansha District Xieming , President of Zhongshan Ophthalmic Hospital Liu Yizhi, Deputy general manager of Yueke Technology Financial Group Liuningxiang and other leaders, experts in the ophthalmology, Vesber’s clients and partners.

“… Vesber has gone through 11 years. As we got a wide range of support and help in the way of innovation, the way is difficult but fortunate. In the days to come, Vesber will create our own professional brand and engaged in the research, development, manufacture and sales of high-tech ophthalmic medical products …”, underlined in the speech of Mr. Gao, the Chairman of Guangzhou Vesber Biotechnology Co.,

Guangzhou Vesber Biotechnology Co., was founded in 2007, after 11 years development, we never forget the initial heart and keep going forward. The main concept of branch is to create all possible conditions for providing better service and better products to our customers and employees’ fruitful work.

FCVB at Retina China 2019

The annual Retina China ended on February 23rd  in the city of Shanghai, China, which attract hundreds of ophthalmologists nationwide together to discuss the latest and hottest ophthalmic topics and developments. At the exhibition, Vesber brings the global innovative product- Foldable Capsular Vitreous Body(FCVB) and organize excellent presentation on daily, which transfer more information to presented ophthalmologists effectively. FCVB is the global innovative product and it is mainly used to treat severe retinal detachment, severe ocular trauma and silicone oil dependent eyes.

On the first day of # Retina China 2019#, Dr. Lin and Dr. Wei reported about their experience and long-term observation with FCVB, which connected with many visitors on the Vesber booth B79 &B80. Our greats thanks to Dr. Lin and Dr. Wei for their excellent presentations.

During the congress, Dr. Gao, developer of FCVB is receiving the interview by a Chinese news media. The global innovative product- Foldable Capsular Vitreous Body gives an opportunity and hope to patients with severe ocular trauma to save their eyeballs.


The First FCVB Operation in Pakistan

The day of Feb, 18th is an important day for Vesber! Dr. Prof. Hussain Ahmad Khaqan at Shaukat Khanum Memorial Cancer Hospital, Pakistan performed the first FCVB implantation surgery on the last Monday (18th, March). After the silicone oil injection, the retina of this 19-years-old patient is still detached and it may turns into the silicone oil dependent eyes with the traditional silicone oil treatment in a large possibilities.

For saving his eyeballs and avoid the destination in using ocular prosthesis, Dr. Prof. Hussain Ahmad Khaqan decided to use the global innovative product- Foldable Capsular Vitreous Body ( FCVB). After the FCVB implantation surgery, all the surgical team is very satisfied with this operation and the postoperative observation. We would like to show our thanks to Dr. Hussain Ahmad Khaqan and his team for the deep understandings and trust to a global innovative product and treatment- Foldable Capsular Vitreous Body.


The First FCVB Operation in Russia

The first FCVB milestone in Russia! With the assistance of our European distributor Mr. Eyes and local reseller Rumex, the first FCVB implantation surgery was performed in Russia at the Rascheskov Eyeclinic in Kazan in this week. Dr. Gao, the developer of FCVB arranged the trip to the Russia especially for providing the surgical assistance. Dr. Alexander Rascheskov assisted by Prof. Dr. Gao operated 3 patients with ocular trauma In one day. FCVB help these patients to save their eyes and avoiding the destination in using the ocular prosthesis. We would like to show our thanks to Dr. Alexander Rascheskov and his team for the deep understandings to a global innovative product and treatment- Foldable Capsular Vitreous Body. We sincerely hope FCVB could be used by more ophthalmologists and could save more patients’ eyeballs.